marijuana stocks news

Vaporin, Inc. (VAPO)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 837   419   183   (28)
Cost of Revenue 424 238 115
Gross Profit 413   181   67   13  
Operating Expenses
Research Development
Selling General and Administrative 1,792 1,659 821 2,975
Non Recurring
Others 7 3 3
Total Operating Expenses
Operating Income or Loss (1,386) (1,481) (757) (2,963)
Income from Continuing Operations
Total Other Income/Expenses Net 81 135 (130) 581
Earnings Before Interest And Taxes (1,305) (1,346) (887) (2,382)
Interest Expense 53 94 251 102
Income Before Tax (1,358) (1,440) (1,138) (2,484)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,358) (1,440) (1,138) (2,484)
Non-recurring Events
Discontinued Operations (537)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,358) (1,440) (1,138) (3,021)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,358) (1,440) (1,138) (3,021)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Green Thumb Industries Inc. (GTBIF) to Open Rise Lake in the Hills in Illinois, Its 55th Store

Green Thumb Industries to Open Rise Lake in the Hills in Illinois,…

GT Biopharma (OXISD) Hires Former Pfizer CMO/Vice President and Senior Director of Oncology Research as CMO

LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / GT Biopharma…

GW Pharmaceuticals plc (GWPH) Announces the Appointment of Three New Independent Members to its Board of Directors

GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its…

Tilray, Inc. (TLRY) Launches New Medical Cannabis Edibles in Canada

Tilray Launches New Medical Cannabis Edibles in Canada Tilray, Inc. (“Tilray”) (Nasdaq…